Growth Metrics

Utah Medical Products (UTMD) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $84.3 million.

  • Utah Medical Products' Cash & Current Investments fell 473.14% to $84.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.3 million, marking a year-over-year decrease of 473.14%. This contributed to the annual value of $83.0 million for FY2024, which is 1065.17% down from last year.
  • Per Utah Medical Products' latest filing, its Cash & Current Investments stood at $84.3 million for Q3 2025, which was down 473.14% from $82.2 million recorded in Q2 2025.
  • Over the past 5 years, Utah Medical Products' Cash & Current Investments peaked at $93.8 million during Q1 2024, and registered a low of $56.0 million during Q1 2021.
  • For the 5-year period, Utah Medical Products' Cash & Current Investments averaged around $77.3 million, with its median value being $82.2 million (2025).
  • In the last 5 years, Utah Medical Products' Cash & Current Investments soared by 4145.1% in 2021 and then crashed by 1117.5% in 2025.
  • Utah Medical Products' Cash & Current Investments (Quarter) stood at $61.0 million in 2021, then increased by 23.09% to $75.1 million in 2022, then increased by 23.74% to $92.9 million in 2023, then fell by 10.65% to $83.0 million in 2024, then rose by 1.56% to $84.3 million in 2025.
  • Its Cash & Current Investments was $84.3 million in Q3 2025, compared to $82.2 million in Q2 2025 and $83.3 million in Q1 2025.